HistoSonics
Develops non-invasive histotripsy platform using focused ultrasound to mechanically destroy tumors without surgery
UndisclosedStrategic
Role not disclosedY
Yosemite
Activity from announced rounds
Activity in this selectionUndisclosed
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $125M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionTen63 Therapeutics
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
$45MStrategic
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed